GI ONCOLOGY

Browse all GI ONCOLOGY
MATTERHORN Analysis Upholds Value of Adjuvant Durvalumab Maintenance Period

GI ONCOLOGY

MATTERHORN Analysis Upholds Value of Adjuvant Durvalumab Maintenance Period

Samuel Cytryn, MD, Rutika Mehta, MD, MB, MPH

EPISODE-III Trial: Adjuvant Aspirin Shows No DFS Benefit in Stage III CRC

GI ONCOLOGY

EPISODE-III Trial: Adjuvant Aspirin Shows No DFS Benefit in Stage III CRC

Young Rho, MD

HEMATOLOGY

Browse all HEMATOLOGY
Understanding Mezigdomide: Mechanism of Action and Early Clinical Development

HEMATOLOGY

Understanding Mezigdomide: Mechanism of Action and Early Clinical Development

Paul G. Richardson, MD, Rahul Gosain, MD, MBA

Rapid Reactions: Expanding Treatment Options in Relapsed/Refractory Multiple Myeloma

HEMATOLOGY

Rapid Reactions: Expanding Treatment Options in Relapsed/Refractory Multiple Myeloma

Paul G. Richardson, MD, Rahul Gosain, MD, MBA